Inhibition of Tumor Necrosis Factor Alpha Alters Resistance to Mycobacterium avium Complex Infection in Mice

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Full description

Saved in:
Bibliographic Details
Published inAntimicrobial Agents and Chemotherapy Vol. 42; no. 9; pp. 2336 - 2341
Main Authors BALA, S, HASTINGS, K. L, KAZEMPOUR, K, INGLIS, S, DEMPSEY, W. L
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.09.1998
Subjects
Animals
Biologic Response Modifiers
Biological and medical sciences
Dexamethasone - pharmacology
Female
Immunomodulators
Medical sciences
Mice
Mice, Inbred C57BL
Mycobacterium avium
Pentoxifylline - pharmacology
Pharmacology. Drug treatments
Thalidomide - pharmacology
Tuberculosis
Tuberculosis - immunology
Tumor Necrosis Factor-alpha
Tumor Necrosis Factor-alpha - analysis
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Intraperitoneal administration
Vasodilator agent
Bacteria
Xanthine derivatives
Antagonist
Sedative
Thalidomide
Tumor necrosis factor α
Immunomodulation
Secretion
Rodentia
Cytokine
Mycobacterium avium
Hypnotic
Biological activity
Infection
Pentoxifylline
Resistance
Vertebrata
Mammalia
Mouse
Mycobacteriales
Animal
Mycobacteriaceae
Actinomycetes
Online AccessGet full text

Cover

More Information
Summary:Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Present address: Food and Drug Administration, Harrisburg, PA 17108.
Corresponding author. Mailing address: Division of Special Pathogen and Immunologic Drug Products (HFD-590), 5600 Fishers Ln., Rockville, MD 20857. Phone: (301) 827-2336. Fax: (301) 827-2523. E-mail: balas@cder.fda.gov.
Present address: Otsuka America Pharmaceutical, Inc., Maryland Office of Clinical Research, Rockville, MD 20850.
ISSN:0066-4804
1098-6596
DOI:10.1128/aac.42.9.2336